Listen Now
Topics Covered
- Overview of Bladder Cancer, including Staging & Grading, in the Context of COVID-19
- Standard of Care
- New Treatment Approaches
- Update on Clinical Trials
- The Role of Diagnostic Technologies, Genomics & Precision Medicine
- Targeted Treatments: Predicting Response to Treatment
- The Emerging Role of Immunotherapy
- Communicating with Your Health Care Team about Quality-of-Life Concerns
- Follow-Up Care Appointments & Plans
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
- Nutrition & Hydration Concerns & Tips
- Questions for Our Panel of Experts
Our Panel of Experts
Gary D. Steinberg, MD
Professor, Department of Urology at NYU Grossman School of Medicine, Director Urology Bladder Cancer Program, Urologist and Surgical Oncologist, NYU Langone Health, Immediate Past Chairperson of the BCAN Scientific Advisory Board
Walter Stadler, MD, FACP
Fred C. Buffett Professor, Dean for Clinical Research, Senior Advisor, Cancer Center Director, University of Chicago
Vadim Koshkin, MD
Genitourinary Medical Oncologist, Assistant Professor, Medicine, School of Medicine, University of California San Francisco
Diana L. Bearden, MS, RD, CSO, LD, CNSC
Oncology Dietitian, Michael E. DeBakey VA Medical Center
Stephanie Chisolm, PhD
Director of Education and Advocacy, Bladder Cancer Advocacy Network (BCAN)
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on August 17, 2022.